Disclosed are imidazopyridazinyl compounds of Formula (I): (I), or pharmaceutically salts and prodrugs thereof, wherein R
3
is C
2-4
alkenyl or a cyclic group, and R
1
and R
2
are defined herein. Also disclosed are methods of using such compounds in the treatment of at least one CYP17 associated condition, such as, for example, cancer, and pharmaceutical compositions comprising such compounds.
揭示了公式(I)的
咪唑吡啶基化合物:(I),或其药物盐和前药,其中R3为C2-4
烯基或环状基团,R1和R2在此定义。还揭示了使用这种化合物治疗至少一种CYP17相关疾病的方法,例如癌症,以及包含这种化合物的制药组合物。